SIRS-Lab, Pfizer Target Sepsis with MDx Tests

The initial focus of the partnership will be on using molecular diagnostics to test for severe fungal blood stream infections and to evaluate the clinical impact and pharmacoeconomics of such an approach.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories